| Title | Author | Year | SCOPUS | PUBMED | ISI | TCI | |
|---|---|---|---|---|---|---|---|
| 1. | Serum MUC5AC mucin as a potential marker for cholangiocarcinoma | Wongkham, S. Boonla, C. Patrakitkomjorn, S. Howard, M. Sripa, B. Wongkham, C. Bhudhisawasdi, V. |
2003 | ||||
| 2. | PKA phosphorylation and 14-3-3 interaction regulate the function of neurofibromatosis type I tumor suppressor, neurofibromin | Feng, L. Patrakitkomjorn, S. Saya, H. |
2004 | ||||
| 3. | The neurofibromatosis type 1 gene product neurofibromin enhances cell motility by regulating actin filament dynamics via the Rho-ROCK-LIMK2-cofilin pathway | Feng, L. Patrakitkomjorn, S. Saya, H. |
2005 | ||||
| 4. | Neurofibromatosis type 1 (NF1) tumor suppressor, neurofibromin, regulates the neuronal differentiation of PC12 cells via its associating protein, CRMP-2 | Patrakitkomjorn, S. Kobayashi, D. Wilson, M.M. Saya, H. |
2008 | ||||
| 5. | A novel TFF2 splice variant (ΔEX2TFF2) correlates with longer overall survival time in cholangiocarcinoma | Kamlua, S. Patrakitkomjorn, S. Jearanaikoon, P. Menheniott, T.R. Giraud, A.S. Limpaiboon, T. |
2012 | ||||
| 6. | Serum adhesion molecule-1 (ICAM-1) as a potential prognostic marker for cholangiocarcinoma patients. | Montira Janan Siriporn Proungvitaya Temduang Limpaiboon Tanakorn Proungvitaya Sittiruk Roytrakul Chaisiri Wongkham Patcharee Jearanaikoon Siri Chur-in Sopit Wongkham |
2012 | ||||
| 7. | Serum alpha(1)beta-glycoprotein and afamin ratio as potential diagnostic and prognostic markers in cholangiocarcinoma | Tolek, A Wongkham, C Proungvitaya, S Silsirivanit, A Roytrakul, S Khuntikeo, N Wongkham, S |
2012 | ||||
| 8. | Ratio disruption of the Δ133p53 and TAp53 isoform equilibrium correlates with poor clinical outcome in intrahepatic cholangiocarcinoma | Nutthasirikul, N. Limpaiboon, T. Leelayuwat, C. Patrakitkomjorn, S. Jearanaikoon, P. |
2013 | ||||
| 9. | DNA methylation levels of OPCML and SFRP1 as diagnostic biomarkers in cholangiocarcinoma | T. Limpaiboon R. Amornpisutt S. Proungvitaya P. Jearanaikoon |
2014 | ||||
| 10. | Serum cathepsin B to cystatin C ratio as a potential marker for the diagnosis of cholangiocarcinoma. | Ammala Monsouvanh Tanakorn Proungvitaya Temduang Limpaiboon Chaisiri Wongkham Sopit Wongkham Vor Luvira Siriporn Proungvitaya |
2014 | ||||
| 11. | DNA methylation level of OPCML and SFRP1: a potential diagnostic biomarker of cholangiocarcinoma. | Rattaya Amornpisutt Siriporn Proungvitaya Patcharee Jearanaikoon Temduang Limpaiboon |
2015 | ||||
| 12. | Total serum bile acid as a potential marker for the diagnosis of cholangiocarcinoma without jaundice. | Sombattheera, S Proungvitaya, T Limpaiboon, T Wongkham, S Wongkham, C Luvira, V Proungvitaya, S |
2015 | ||||
| 13. | Abstract A37: Aberrant DNA methylation of HTATIP2 and UCH-L1 as prognostic and predictive biomarkers for cholangiocarcinoma | Temduang Limpaiboon Chaiyachet Nanok Siriporn Proungvitaya Patcharee Jearanaikoon Ake Pugkhem Anucha Puapairoj |
2016 | ||||
| 14. | High expression of apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) in human cholangiocarcinoma | Chua-On, D Proungvitaya, T Techasen, A Limpaiboon, T Roytrakul, S Wongkham, S Wongkham, C Somintara, O Sungkhamanon, S Proungvitaya, S |
2016 | ||||
| 15. | Diagnostic value of serum bile acid composition patterns and serum glycocholic acid levels in cholangiocarcinoma. | Patrakitkomjorn, S. Sombattheera, S. Boonsiri, P. Limpaiboon, T. Wongkham, C. Titapun, A. Proungvitaya, T. |
2017 | ||||
| 16. | High expression of CCDC25 in cholangiocarcinoma tissue samples | Proungvitaya, S Klinthong, W Proungvitaya, T Limpaiboon, T Jearanaikoon, P Roytrakul, S Wongkham, C Nimboriboonporn, A Wongkham, S |
2017 | ||||
| 17. | Aberrant methylation of HTATIP2 and UCHL1 as a predictive biomarker for Cholangiocarcinoma | Chaiyachet Nanok Patcharee Jearanaikoon Siriporn Proungvitaya Temduang Limpaiboon |
2018 | ||||
| 18. | High levels of APEX1 in sera from patients with cholangiocarcinoma | Tanakorn Proungvitaya Siriporn Proungvitaya Doungdean Tummanatsakun Sittiruk Roytrakul |
2018 | ||||
| 19. | Methylation of UCHL1 as a prognostic biomarker for cholangiocarcinoma | Chaiyachet Nanok Chanvit Leelayuwat Patcharee Jearanaikoon Siriporn Proungvitaya Temduang Limpaiboon |
2018 | ||||
| 20. | Serum pyruvate dehydrogenase kinase 3 as a prognostic marker for cholangiocarcinoma | Siriporn Proungvitaya Tanakorn Proungvitaya Surangkana Sanmai Sittiruk Roytrakul |
2018 | ||||
| 21. | Overexpression of polycomb repressive complex 2 key components EZH2/SUZ12/EED as an unfavorable prognostic marker in cholangiocarcinoma. | Settasatian, C. Patrakitkomjorn, S. Limpaiboon, T. |
2019 | ||||
| 22. | Serum apurinic/apyrimidinic endodeoxyribonuclease 1 (APEX1) level as a potential biomarker of cholangiocarcinoma | Doungdean Tummanatsakun Tanakorn Proungvitaya Sittiruk Roytrakul Temduang Limpaiboon Sopit Wongkham Chaisiri Wongkham Atit Silsirivanit Ongart Somintara Sakkarn Sangkhamanon Siriporn Proungvitaya |
2019 | ||||
| 23. | Serum cell-free DNA methylation of OPCML and HOXD9 as a biomarker that may aid in differential diagnosis between cholangiocarcinoma and other biliary diseases | Wasenang, W Chaiyarit, P Proungvitaya, S Limpaiboon, T |
2019 | ||||
| 24. | Serum pyruvate dehydrogenase kinase as a prognostic marker for cholangiocarcinoma | Sanmai, S Proungvitaya, T Limpaiboon, T Chua-On, D Seubwai, W Roytrakul, S Wongkham, S Wongkham, C Somintara, O Sangkhamanon, S Proungvitaya, S |
2019 | ||||
| 25. | The Upregulation of OCT4 in Acidic Extracellular pH is Associated with Gemcitabine Resistance in Cholangiocarcinoma Cell Lines. | Patrakitkomjorn, S. Jearanaikoon, P. Limpaiboon, T. |
2019 | ||||
| 26. | Influence of Gold Nanoparticles with Different Surface Charges on Localization and Monocyte Behavior | Srijampa, S Buddhisa, S Ngernpimai, S Leelayuwat, C Proungvitaya, S Chompoosor, A Tippayawat, P |
2020 | ||||
| 27. | Serum coiled-coil domain containing 25 protein as a potential screening/diagnostic biomarker for cholangiocarcinoma | Proungvitaya, T. Limpaiboon, T. Jusakul, A. Titapun, A. Patrakitkomjorn, S. |
2020 | Count | 17 | 15 | 19 | 0 |
| Title | Authors | Year | Publication name | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | Total | ||||||
| 1. | Serum MUC5AC mucin as a potential marker for cholangiocarcinoma | Wongkham, S. Boonla, C. Patrakitkomjorn, S. Howard, M. Sripa, B. Wongkham, C. Bhudhisawasdi, V. |
2003 |
Cancer Letters 1 (195), pp. 93-99 |
||||||||
| 2. | PKA phosphorylation and 14-3-3 interaction regulate the function of neurofibromatosis type I tumor suppressor, neurofibromin | Feng, L. Patrakitkomjorn, S. Saya, H. |
2004 |
FEBS Letters 1-3 (557), pp. 275-282 |
||||||||
| 3. | The neurofibromatosis type 1 gene product neurofibromin enhances cell motility by regulating actin filament dynamics via the Rho-ROCK-LIMK2-cofilin pathway | Feng, L. Patrakitkomjorn, S. Saya, H. |
2005 |
Journal of Biological Chemistry 47 (280), pp. 39524-39533 |
||||||||
| 4. | Neurofibromatosis type 1 (NF1) tumor suppressor, neurofibromin, regulates the neuronal differentiation of PC12 cells via its associating protein, CRMP-2 | Patrakitkomjorn, S. Kobayashi, D. Wilson, M.M. Saya, H. |
2008 |
Journal of Biological Chemistry 14 (283), pp. 9399-9413 |
||||||||
| 5. | A novel TFF2 splice variant (ΔEX2TFF2) correlates with longer overall survival time in cholangiocarcinoma | Kamlua, S. Patrakitkomjorn, S. Jearanaikoon, P. Menheniott, T.R. Giraud, A.S. Limpaiboon, T. |
2012 |
Oncology Reports 4 (27), pp. 1207-1212 |
||||||||
| 6. | Ratio disruption of the Δ133p53 and TAp53 isoform equilibrium correlates with poor clinical outcome in intrahepatic cholangiocarcinoma | Nutthasirikul, N. Limpaiboon, T. Leelayuwat, C. Patrakitkomjorn, S. Jearanaikoon, P. |
2013 |
International Journal of Oncology 4 (42), pp. 1181-1188 |
||||||||
| 7. | High expression of apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) in human cholangiocarcinoma | Proungvitaya, T. Techasen, A. Limpaiboon, T. Wongkham, S. Wongkham, C. Somintara, O. Patrakitkomjorn, S. |
2016 |
Tumor Biology (), pp. 1-9 |
||||||||
| 8. | Diagnostic value of serum bile acid composition patterns and serum glycocholic acid levels in cholangiocarcinoma | Patrakitkomjorn, S. Sombattheera, S. Boonsiri, P. Limpaiboon, T. Wongkham, C. Titapun, A. Proungvitaya, T. |
2017 |
Oncology Letters 4 (14), pp. 4943-4948 |
||||||||
| 9. | High expression of CCDC25 in cholangiocarcinoma tissue samples | Patrakitkomjorn, S. Proungvitaya, T. Limpaiboon, T. Jearanaikoon, P. Wongkham, C. |
2017 |
Oncology Letters 2 (14), pp. 2566-2572 |
||||||||
| 10. | Aberrant methylation of HTATIP2 and UCHL1 as a predictive biomarker for Cholangiocarcinoma | Nanok, C. Jearanaikoon, P. Patrakitkomjorn, S. Limpaiboon, T. |
2018 |
Molecular Medicine Reports 3 (17), pp. 4145-4153 |
||||||||
| 11. | Overexpression of polycomb repressive complex 2 key components EZH2/SUZ12/EED as an unfavorable prognostic marker in cholangiocarcinoma | Settasatian, C. Patrakitkomjorn, S. Limpaiboon, T. |
2019 |
Pathology Research and Practice 7 (215), pp. |
||||||||
| 12. | Serum apurinic/apyrimidinic endodeoxyribonuclease 1 (APEX1) level as a potential biomarker of cholangiocarcinoma | Proungvitaya, T. Limpaiboon, T. Wongkham, S. Wongkham, C. Silsirivanit, A. Somintara, O. Patrakitkomjorn, S. |
2019 |
Biomolecules 9 (9), pp. |
||||||||
| 13. | Serum cell-free DNA methylation of OPCML and HOXD9 as a biomarker that may aid in differential diagnosis between cholangiocarcinoma and other biliary diseases | Chaiyarit, P. Patrakitkomjorn, S. Limpaiboon, T. |
2019 |
Clinical Epigenetics 1 (11), pp. |
||||||||
| 14. | Serum pyruvate dehydrogenase kinase as a prognostic marker for cholangiocarcinoma | Proungvitaya, T. Limpaiboon, T. Seubwai, W. Wongkham, S. Wongkham, C. Somintara, O. Patrakitkomjorn, S. |
2019 |
Oncology Letters 6 (17), pp. 5275-5282 |
||||||||
| 15. | The upregulation of OCT4 in acidic extracellular pH is associated with gemcitabine resistance in cholangiocarcinoma cell lines | Patrakitkomjorn, S. Jearanaikoon, P. Limpaiboon, T. |
2019 |
Asian Pacific Journal of Cancer Prevention 9 (20), pp. 2745-2748 |
||||||||
| 16. | Influence of Gold Nanoparticles with Different Surface Charges on Localization and Monocyte Behavior | Buddhisa, S. Ngernpimai, S. Leelayuwat, C. Patrakitkomjorn, S. Chompoosor, A. Tippayawat, P. |
2020 |
Bioconjugate Chemistry (), pp. |
||||||||
| 17. | Serum coiled-coil domain containing 25 protein as a potential screening/diagnostic biomarker for cholangiocarcinoma | Proungvitaya, T. Limpaiboon, T. Jusakul, A. Titapun, A. Patrakitkomjorn, S. |
2020 |
Oncology Letters 1 (19), pp. 930-942 |
||||||||
| Title | Authors | Year | Journal title | ||
|---|---|---|---|---|---|
| 1. | Serum α1β-glycoprotein and afamin ratio as potential diagnostic and prognostic markers in cholangiocarcinoma. | Tolek, A Wongkham, C Proungvitaya, S Silsirivanit, A Roytrakul, S Khuntikeo, N Wongkham, S |
2012 |
Experimental biology and medicine (Maywood, N.J.) 10 (237), pp. 1142-9 |
|
| 2. | Serum adhesion molecule-1 (ICAM-1) as a potential prognostic marker for cholangiocarcinoma patients. | Janan, M Proungvitaya, S Limpaiboon, T Proungvitaya, T Roytrakul, S Wongkham, C Jearanaikoon, P Chur-in, S Wongkham, S |
2012 |
Asian Pacific journal of cancer prevention : APJCP (13), pp. 107-14 |
|
| 3. | Serum cathepsin B to cystatin C ratio as a potential marker for the diagnosis of cholangiocarcinoma. | Monsouvanh, A Proungvitaya, T Limpaiboon, T Wongkham, C Wongkham, S Luvira, V Proungvitaya, S |
2014 |
Asian Pacific journal of cancer prevention : APJCP 21 (15), pp. 9511-5 |
|
| 4. | Total serum bile acid as a potential marker for the diagnosis of cholangiocarcinoma without jaundice. | Sombattheera, S Proungvitaya, T Limpaiboon, T Wongkham, S Wongkham, C Luvira, V Proungvitaya, S |
2015 |
Asian Pacific journal of cancer prevention : APJCP 4 (16), pp. 1367-70 |
|
| 5. | DNA methylation level of OPCML and SFRP1: a potential diagnostic biomarker of cholangiocarcinoma. | Amornpisutt, R Proungvitaya, S Jearanaikoon, P Limpaiboon, T |
2015 |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 7 (36), pp. 4973-8 |
|
| 6. | High expression of apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) in human cholangiocarcinoma. | Chua-On, D Proungvitaya, T Techasen, A Limpaiboon, T Roytrakul, S Wongkham, S Wongkham, C Somintara, O Sungkhamanon, S Proungvitaya, S |
2016 |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 10 (37), pp. 13659-13667 |
|
| 7. | High expression of CCDC25 in cholangiocarcinoma tissue samples. | Proungvitaya, S Klinthong, W Proungvitaya, T Limpaiboon, T Jearanaikoon, P Roytrakul, S Wongkham, C Nimboriboonporn, A Wongkham, S |
2017 |
Oncology letters 2 (14), pp. 2566-2572 |
|
| 8. | Diagnostic value of serum bile acid composition patterns and serum glycocholic acid levels in cholangiocarcinoma. | Proungvitaya, S Sombattheera, S Boonsiri, P Limpaiboon, T Wongkham, S Wongkham, C Titapun, A Proungvitaya, T |
2017 |
Oncology letters 4 (14), pp. 4943-4948 |
|
| 9. | Aberrant methylation of HTATIP2 and UCHL1 as a predictive biomarker for cholangiocarcinoma. | Nanok, C Jearanaikoon, P Proungvitaya, S Limpaiboon, T |
2018 |
Molecular medicine reports 3 (17), pp. 4145-4153 |
|
| 10. | Serum cell-free DNA methylation of OPCML and HOXD9 as a biomarker that may aid in differential diagnosis between cholangiocarcinoma and other biliary diseases. | Wasenang, W Chaiyarit, P Proungvitaya, S Limpaiboon, T |
2019 |
Clinical epigenetics 1 (11), pp. 39 |
|
| 11. | Overexpression of polycomb repressive complex 2 key components EZH2/SUZ12/EED as an unfavorable prognostic marker in cholangiocarcinoma. | Wasenang, W Puapairoj, A Settasatian, C Proungvitaya, S Limpaiboon, T |
2019 |
Pathology, research and practice (), pp. 152451 |
|
| 12. | Serum pyruvate dehydrogenase kinase as a prognostic marker for cholangiocarcinoma. | Sanmai, S Proungvitaya, T Limpaiboon, T Chua-On, D Seubwai, W Roytrakul, S Wongkham, S Wongkham, C Somintara, O Sangkhamanon, S Proungvitaya, S |
2019 |
Oncology letters 6 (17), pp. 5275-5282 |
|
| 13. | The Upregulation of OCT4 in Acidic Extracellular pH is Associated with Gemcitabine Resistance in Cholangiocarcinoma Cell Lines. | Choodetwattana, P Proungvitaya, S Jearanaikoon, P Limpaiboon, T |
2019 |
Asian Pacific journal of cancer prevention : APJCP 9 (20), pp. 2745-2748 |
|
| 14. | Serum coiled-coil domain containing 25 protein as a potential screening/diagnostic biomarker for cholangiocarcinoma. | Chanakankun, R Proungvitaya, T Chua-On, D Limpaiboon, T Roytrakul, S Jusakul, A Titapun, A Jarearnrat, A Proungvitaya, S |
2020 |
Oncology letters 1 (19), pp. 930-942 |
|
| 15. | Influence of Gold Nanoparticles with Different Surface Charges on Localization and Monocyte Behavior. | Srijampa, S Buddhisa, S Ngernpimai, S Leelayuwat, C Proungvitaya, S Chompoosor, A Tippayawat, P |
2020 |
Bioconjugate chemistry 4 (31), pp. 1133-1143 |
| Title | Authors | Year | Journal title | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | Total | ||||||
| 1. | Serum Adhesion Molecule-1 (ICAM-1) as a Potential Prognostic Marker for Cholangiocarcinoma Patients | Montira Janan Siriporn Proungvitaya Temduang Limpaiboon Tanakorn Proungvitaya Sittiruk Roytrakul Chaisiri Wongkham Patcharee Jearanaikoon Siri Chur-in Sopit Wongkham |
2012 |
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (13.0), pp. 107.0-114.0 |
7 | 0 | 0 | 0 | 0 | 0 | 7 | |
| 2. | Serum alpha(1)beta-glycoprotein and afamin ratio as potential diagnostic and prognostic markers in cholangiocarcinoma | Arthit Tolek Chaisiri Wongkham Siriporn Proungvitaya Atit Silsirivanit Sittiruk Roytrakul Narong Khuntikeo Sopit Wongkham |
2012 |
EXPERIMENTAL BIOLOGY AND MEDICINE 10.0 (237.0), pp. 1142.0-1149.0 |
20 | 0 | 0 | 0 | 0 | 0 | 20 | |
| 3. | DNA methylation levels of OPCML and SFRP1 as diagnostic biomarkers in cholangiocarcinoma | T. Limpaiboon R. Amornpisutt S. Proungvitaya P. Jearanaikoon |
2014 |
EUROPEAN JOURNAL OF CANCER (50.0), pp. S98-S98 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 4. | Serum Cathepsin B to Cystatin C Ratio as a Potential Marker for the Diagnosis of Cholangiocarcinoma | Ammala Monsouvanh Tanakorn Proungvitaya Temduang Limpaiboon Chaisiri Wongkham Sopit Wongkham Vor Luvira Siriporn Proungvitaya |
2014 |
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION 21.0 (15.0), pp. 9511.0-9515.0 |
17 | 0 | 0 | 0 | 0 | 0 | 17 | |
| 5. | DNA methylation level of OPCML and SFRP1: a potential diagnostic biomarker of cholangiocarcinoma | Rattaya Amornpisutt Siriporn Proungvitaya Patcharee Jearanaikoon Temduang Limpaiboon |
2015 |
TUMOR BIOLOGY 7.0 (36.0), pp. 4973.0-4978.0 |
24 | 0 | 0 | 0 | 0 | 0 | 24 | |
| 6. | Abstract A37: Aberrant DNA methylation of HTATIP2 and UCH-L1 as prognostic and predictive biomarkers for cholangiocarcinoma | Temduang Limpaiboon Chaiyachet Nanok Siriporn Proungvitaya Patcharee Jearanaikoon Ake Pugkhem Anucha Puapairoj |
2016 |
CANCER RESEARCH (76.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 7. | High expression of apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) in human cholangiocarcinoma | Daraporn Chua-on Tanakorn Proungvitaya Anchalee Techasen Temduang Limpaiboon Sittiruk Roytrakul Sopit Wongkham Chaisiri Wongkham Ongart Somintara Sakkarn Sungkhamanon Siriporn Proungvitaya |
2016 |
TUMOR BIOLOGY 10.0 (37.0), pp. 13659.0-13667.0 |
17 | 0 | 0 | 0 | 0 | 0 | 17 | |
| 8. | Diagnostic value of serum bile acid composition patterns and serum glycocholic acid levels in cholangiocarcinoma | Siriporn Proungvitaya Sutthikan Sombattheera Patcharee Boonsiri Temduang Limpaiboon Sopit Wongkham Chaisiri Wongkham Attapol Titapun Tanakorn Proungvitaya |
2017 |
ONCOLOGY LETTERS 4.0 (14.0), pp. 4943.0-4948.0 |
6 | 0 | 0 | 0 | 0 | 0 | 6 | |
| 9. | High expression of CCDC25 in cholangiocarcinoma tissue samples | Siriporn Proungvitaya Wachiraya Klinthong Tanakorn Proungvitaya Temduang Limpaiboon Patcharee Jearanaikoon Sittiruk Roytrakul Chaisiri Wongkham Anongporn Nimboriboonporn Sopit Wongkham |
2017 |
ONCOLOGY LETTERS 2.0 (14.0), pp. 2566.0-2572.0 |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 10. | Aberrant methylation of HTATIP2 and UCHL1 as a predictive biomarker for cholangiocarcinoma | Chaiyachet Nanok Patcharee Jearanaikoon Siriporn Proungvitaya Temduang Limpaiboon |
2018 |
MOLECULAR MEDICINE REPORTS 3.0 (17.0), pp. 4145.0-4153.0 |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 11. | High levels of APEX1 in sera from patients with cholangiocarcinoma | Tanakorn Proungvitaya Siriporn Proungvitaya Doungdean Tummanatsakun Sittiruk Roytrakul |
2018 |
CANCER SCIENCE (109.0), pp. 955.0-955.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 12. | Methylation of UCHL1 as a prognostic biomarker for cholangiocarcinoma | Chaiyachet Nanok Chanvit Leelayuwat Patcharee Jearanaikoon Siriporn Proungvitaya Temduang Limpaiboon |
2018 |
CANCER SCIENCE (109.0), pp. 243.0-243.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 13. | Serum pyruvate dehydrogenase kinase 3 as a prognostic marker for cholangiocarcinoma | Siriporn Proungvitaya Tanakorn Proungvitaya Surangkana Sanmai Sittiruk Roytrakul |
2018 |
CANCER SCIENCE (109.0), pp. 955.0-955.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 14. | Overexpression of polycomb repressive complex 2 key components EZH2/SUZ12/EED as an unfavorable prognostic marker in cholangiocarcinoma | Wiphawan Wasenang Anucha Puapairoj Chatri Settasatian Siriporn Proungvitaya Temduang Limpaiboon |
2019 |
PATHOLOGY RESEARCH AND PRACTICE 7.0 (215.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 15. | Serum Apurinic/Apyrimidinic Endodeoxyribonuclease 1 (APEX1) Level as a Potential Biomarker of Cholangiocarcinoma | Doungdean Tummanatsakun Tanakorn Proungvitaya Sittiruk Roytrakul Temduang Limpaiboon Sopit Wongkham Chaisiri Wongkham Atit Silsirivanit Ongart Somintara Sakkarn Sangkhamanon Siriporn Proungvitaya |
2019 |
BIOMOLECULES 9.0 (9.0), pp. |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 16. | Serum cell-free DNA methylation of OPCML and HOXD9 as a biomarker that may aid in differential diagnosis between cholangiocarcinoma and other biliary diseases | Wiphawan Wasenang Ponlatham Chaiyarit Siriporn Proungvitaya Temduang Limpaiboon |
2019 |
CLINICAL EPIGENETICS (11.0), pp. |
14 | 0 | 0 | 0 | 0 | 0 | 14 | |
| 17. | Serum pyruvate dehydrogenase kinase as a prognostic marker for cholangiocarcinoma | Surangkana Sanmai Tanakorn Proungvitaya Temduang Limpaiboon Daraporn Chua-On Wunchana Seubwai Sittiruk Roytrakul Sopit Wongkham Chaisiri Wongkham Ongart Somintara Sakkarn Sangkhamanon Siriporn Proungvitaya |
2019 |
ONCOLOGY LETTERS 6.0 (17.0), pp. 5275.0-5282.0 |
2 | 0 | 0 | 0 | 0 | 0 | 2 | |
| 18. | Influence of Gold Nanoparticles with Different Surface Charges on Localization and Monocyte Behavior | Sukanya Srijampa Surachat Buddhisa Sawinee Ngernpimai Chanvit Leelayuwat Siriporn Proungvitaya Apiwat Chompoosor Patcharaporn Tippayawat |
2020 |
BIOCONJUGATE CHEMISTRY 4.0 (31.0), pp. 1133.0-1143.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 19. | Serum coiled-coil domain containing 25 protein as a potential screening/diagnostic biomarker for cholangiocarcinoma | Ravinnipa Chanakankun Tanakorn Proungvitaya Daraporn Chua-On Temduang Limpaiboon Sittiruk Roytrakul Apinya Jusakul Attapol Titapun Apiwat Jarearnrat Siriporn Proungvitaya |
2020 |
ONCOLOGY LETTERS 1.0 (19.0), pp. 930.0-942.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Title | Authors | Year | Journal title |
|---|
| Title | Authors | NRIIS type | Year | NRIIS Scholarship |
|---|